Success Metrics

Clinical Success Rate
71.4%

Based on 5 completed trials

Completion Rate
71%(5/7)
Active Trials
2(17%)
Results Posted
0%(0 trials)
Terminated
2(17%)

Phase Distribution

Ph phase_2
1
8%
Ph phase_1
1
8%
Ph not_applicable
3
25%

Phase Distribution

1

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
1(20.0%)
N/ANon-phased studies
3(60.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

62.5%

5 of 8 finished

Non-Completion Rate

37.5%

3 ended early

Currently Active

2

trials recruiting

Total Trials

12

all time

Status Distribution
Active(2)
Completed(5)
Terminated(3)
Other(2)

Detailed Status

Completed5
unknown2
Terminated2
Recruiting2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
2
Success Rate
71.4%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (20.0%)
Phase 21 (20.0%)
N/A3 (60.0%)

Trials by Status

unknown217%
withdrawn18%
terminated217%
completed542%
recruiting217%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
12